The president requested a budget of $234 million more than the approved budget. The FDA’s total budget, which includes user fees, is $3.8 billion. The House is set to vote on the final report this week.
Related Articles on the FDA:
FDA Opens Comment Period on Device Reclassification Process
10 Recent FDA Drug and Medical Device Decisions
FDA Approves Carestream’s Vue Motion Medical Image Viewer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.